Oscotec Inc. | Cash Flow

Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
Net Income before Extraordinaries
3,937
2,057
363
4,869
4,276
Depreciation, Depletion & Amortization
410
412
514
447
374
Other Funds
296
22
59
244
639
Funds from Operations
42
659
1,010
1,010
1,307
Changes in Working Capital
1,304
1,303
365
2,360
1,965
Net Operating Cash Flow
1,346
1,962
645
3,369
658
Capital Expenditures
1,700
2,972
4,162
7,075
5,637
Sale of Fixed Assets & Businesses
1
23
6
4,825
7
Purchase/Sale of Investments
3,872
1,453
7,058
5,964
2,887
Net Investing Cash Flow
2,548
382
10,434
5,886
1,644
Issuance/Reduction of Debt, Net
1,895
93
7,157
5,292
10,000
Net Financing Cash Flow
1,557
1,379
10,112
1,329
17,861
Net Change in Cash
344
201
325
1,183
16,411
Free Cash Flow
1,409
2,120
536
3,409
597
Other Sources
814
2,164
884
2,306
1,158
Change in Capital Stock
635
1,493
3,014
3,719
7,221
Exchange Rate Effect
-
10
1
5
464
Other Uses
438
285
103
133
59

About Oscotec

View Profile
Address
9/F, Korea Bio Park A
Seongnam GY 13488
Korea, Republic Of
Employees -
Website http://www.oscotec.com
Updated 09/14/2018
Oscotec, Inc. engages in the development and manufacture of pharmaceutical products. Its products include drugs for osteoporosis, arthritis, periodontal disease and cancer; functional food ingredients, dental bone graft materials, dental membrane and dental supplies. The company was founded on December 8, 1998 and is headquartered in Seongnam, South Korea.